688089 Stock | | | 18.28 0.19 1.05% |
Cabio Biotech financial indicator trend analysis is way more than just evaluating Cabio Biotech Wuhan prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cabio Biotech Wuhan is a good investment. Please check the relationship between Cabio Biotech Other Operating Expenses and its Net Income From Continuing Ops accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabio Biotech Wuhan. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Other Operating Expenses vs Net Income From Continuing Ops
Other Operating Expenses vs Net Income From Continuing Ops Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cabio Biotech Wuhan Other Operating Expenses account and
Net Income From Continuing Ops. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Cabio Biotech's Other Operating Expenses and Net Income From Continuing Ops is -0.42. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Cabio Biotech Wuhan, assuming nothing else is changed. The correlation between historical values of Cabio Biotech's Other Operating Expenses and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Cabio Biotech Wuhan are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Other Operating Expenses i.e., Cabio Biotech's Other Operating Expenses and Net Income From Continuing Ops go up and down completely randomly.
Correlation Coefficient | -0.42 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cabio Biotech Wuhan. It is also known as Cabio Biotech overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Net Income From Continuing Ops
Most indicators from Cabio Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cabio Biotech Wuhan current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabio Biotech Wuhan. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
The current year's
Tax Provision is expected to grow to about 17.8
M, whereas
Selling General Administrative is forecasted to decline to about 35.2
M.
Cabio Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Cabio Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cabio Biotech fundamental ratios Accounts
Currently Active Assets on Macroaxis
Other Information on Investing in Cabio Stock
Balance Sheet is a snapshot of the
financial position of Cabio Biotech Wuhan at a specified time, usually calculated after every quarter, six months, or one year. Cabio Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cabio Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cabio currently owns. An asset can also be divided into two categories, current and non-current.